Niosomes as Carrier in Dermal Drug Delivery

  title={Niosomes as Carrier in Dermal Drug Delivery},
  author={Yahya Rahimpour and Hamed Hamishehkar},
© 2012 Rahimpour and Hamishehkar, licen see InTech. This is an open a ccess chapter distributed under the terms of the Creative Commons Attribution License (h ttp:// /licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Figures from this paper

Effect of NDDS on Polyherbal Formulation
In India, in ancient times, people used plant materials to make drug polyherbal formulations. Herbal drugs have enormous therapeutic potential which can be explored through various beneficial drugExpand
Proniosomes : Innovative Vesicular Drug Delivery System : A Review N Review
  • 2019
International Journal of Pharmaceutical Sciences Review and Research International Journal of Pharmaceutical Sciences Review and Research Available online at ©CopyrightExpand
Novel Approaches in Herbal Formulations
Herbal medications have restorative potential, which can be given through different advantageous medication conveyance frameworks. Utilizing the bioactive and plant extricates, the assortment ofExpand
Topical delivery of artemether, encapsulated in niosome and proniosome carriers
A concise and factual abstract is required that states briefly the purpose of the research, the principal results and major conclusions, and must not exceed 200 words. Expand
Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives.
This review explores and criticizes the numerous attempts that were adopted through the years to entrap/encapsulate this valuable drug in nanocarriers aiming to reach its most appropriate and successful delivery system. Expand
Treatment of infectious diseases and immunisation has undergone a revolutionary shift in recent years. Not only a large number of disease-specific biological have been developed, but also emphasisExpand
In this review an effeort has been made to document the key concepts relating to niosomes an the advances that have been made in terms of research in the field of niosomal drug delivery. Expand
Novel approaches in treatment of Acne vulgaris: Patents related to micro/nanoparticulated carrier systems
Acne vulgaris (acne) is chronic inflammatory dermatosis which affects the pilosebaceous unit, with a varied clinical picture including inflammatory and non-inflammatory cutaneous lessions. ThisExpand
Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery
Niosomal vesicles represented to be an efficient and stable vesicular carrier for transdermal delivery of buflomedil hydrochloride patch containing a stable formulation with improved drug permeation. Expand
Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma
The objective of the present study was to develop niosomal gels loaded with Timolol Maleate (TM), Non-selective beta-adrenergic receptor antagonist, for prolonged duration and improvedExpand


Non‐ionic surfactant vesicles, niosomes, as a delivery system for the anti‐leishmanial drug, sodium stibogluconate
Niosomal sodium stibogluconate was shown to be more active than free drug against experimental murine visceral leishmaniasis, an effect apparently dependent on maintaining high drug levels in the infected reticuloendothelial system. Expand
Formulation and Evaluation of Miconazole Niosomes
This study was to investigate the feasibility of using niosome as a transdermal drug delivery system for Miconazole. Topically applied niosomes can increase residence time of drug in the stratumExpand
Niosomes As Drug Carriers
The concept of carriers to deliver drugs to target organs and modify drug disposition has been widely discussed1. The majority of such reports have concerned the use of phospholipid vesicles orExpand
Liposomes and Niosomes as Topical Drug Delivery Systems
The effect of liposomes and niosomes on enhancing drug penetration, and the effect of composition, size and type of the vesicular system on TT delivery are defined. Expand
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Evaluated transdermal potential of novel vesicular carrier, ethosomes, bearing methotrexate (MTX), an anti-psoriatic, anti-neoplastic, highly hydrosoluble agent, suggests that ethosomes are an efficient carrier for dermal andtransdermal delivery of MTX. Expand
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol.
The in vitro permeation study using mouse abdominal skin shows significantly enhanced permeation with vesicles as indicated by flux of dithranol from liposomes and niosomes as compared with the cream base. Expand
Harmine: Evaluation of its Antileishmanial Properties in Various Vesicular Delivery Systems
Because of its appreciable efficacy in destroying intracellular parasites as well as non-hepatotoxic and non-nephrotoxic nature, harmine, in the vesicular forms, may be considered for clinical application in humans. Expand
Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects
For these novel delivery methods to succeed and compete with those already on the market, the prime issues that require consideration include device design and safety, efficacy, ease of handling, and cost-effectiveness. Expand
Niosomes in sustained and targeted drug delivery: some recent advances
The current status and potential of niosomes in drug delivery with special attention to their role in drug targeting are considered and their methods of preparation, formulation aspects, advantages, limitations, and applications are discussed. Expand
Ultra deformable niosomes for improved transdermal drug delivery: The future scenario
Topical route of delivery is the most popular with use of ointments, creams, lotions, gels and transdermal patches. It is preferred over oral dosage forms to avoid gastric irritation, multiple dosageExpand